Advanced search
Publication Cover
Leukemia & Lymphoma Volume 64, 2023 - Issue 10
Submit an article Journal homepage
143
Views
0
CrossRef citations to date
0
Altmetric
Letters to the Editor

Prolonged 3-year spontaneous remission of diffuse large B-cell lymphoma upon withdrawal of infliximab and late relapse in a patient with psoriasis: a case report and review of the literature

John V. Asimakopoulosa Department of Haematology and Bone Marrow Transplantation, National and Kapodistrian University of Athens, Laikon General Hospital, Athens, GreeceORCID Iconhttps://orcid.org/0000-0003-1118-1700
ORCID Icon,
Filippos Dolkirasb Department of Pathology, Evangelismos Hospital, Athens, Greece
,
Eleftheria Lakiotakic First Department of Pathology, National and Kapodistrian University of Athens, Laikon General Hospital, Athens, Greece
,
Phivi Rondogiannid Department of Nuclear Medicine and PET/CT, Evangelismos Hospital, Athens, Greece
,
Gerasimos Tsourouflise Second Department of Surgery, Propedeutic, National and Kapodistrian University of Athens, Laikon General Hospital, Athens, Greece
,
Marina P. Siakantarisa Department of Haematology and Bone Marrow Transplantation, National and Kapodistrian University of Athens, Laikon General Hospital, Athens, Greece
,
Maria K. Angelopouloua Department of Haematology and Bone Marrow Transplantation, National and Kapodistrian University of Athens, Laikon General Hospital, Athens, Greece
,
Dimitra Rondogiannib Department of Pathology, Evangelismos Hospital, Athens, Greece
,
Penelope Korkolopoulouc First Department of Pathology, National and Kapodistrian University of Athens, Laikon General Hospital, Athens, Greece
,
Panayiotis Vlahoyiannopoulosf Department of Pathophysiology, National and Kapodistrian University of Athens, Laikon General Hospital, Athens, Greece
&
Theodoros P. Vassilakopoulosa Department of Haematology and Bone Marrow Transplantation, National and Kapodistrian University of Athens, Laikon General Hospital, Athens, GreeceCorrespondence[email protected] [email protected]
ORCID Iconhttps://orcid.org/0000-0001-8766-1853
ORCID Icon show all
Pages 1695-1700 | Received 03 Feb 2023, Accepted 26 Jun 2023, Published online: 26 Jul 2023

References

  • Trafford AM, Parisi R, Kontopantelis E, et al. Association of psoriasis with the risk of developing or dying of ­cancer: a systematic review and meta-analysis. JAMA Dermatol. 2019;155(12):1390–1403. doi:10.1001/jamadermatol.2019.3056
  • Fuxench ZCC, Shin DB, Beatty AO, et al. The risk of cancer in patients with psoriasis: a population-based cohort study in the health improvement network. JAMA Dermatol. 2016;152(3):282–290. doi:10.1001/jamadermatol.2015.4847
  • Garcia-Doval I, Descalzo MA, Mason KJ, et al. Cumulative exposure to biological therapy and risk of cancer in patients with psoriasis: a meta-analysis of psonet studies from Israel, Italy, Spain, the U.K. and republic of Ireland. Br J Dermatol. 2018;179(4):863–871. doi:10.1111/bjd.16715
  • Brown SL, Greene MH, Gershon SK, et al. Tumor necrosis factor antagonist therapy and lymphoma development: twenty-six cases reported to the food and drug administration. Arthritis Rheum. 2002;46(12):3151–3158. doi:10.1002/art.10679
  • Swerdlow SH, Campo E, Pileri SA, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127(20):2375–2390. doi:10.1182/blood-2016-01-643569
  • Asgari MM, Ray GT, Geier JL, et al. Malignancy rates in a large cohort of patients with systemically treated psoriasis in a managed care population. J Am Acad Dermatol. 2017;76(4):632–638. doi:10.1016/j.jaad.2016.10.006
  • Dommasch ED, Abuabara K, Shin DB, et al. The risk of infection and malignancy with tumor necrosis factor antagonists in adults with psoriatic disease: a systematic review and meta-analysis of randomized controlled trials. J Am Acad Dermatol. 2011;64(6):1035–1050. doi:10.1016/j.jaad.2010.09.734
  • Gelfand JM, Shin DB, Neimann AL, et al. The risk of lymphoma in patients with psoriasis. J Invest Dermatol. 2006;126(10):2194–2201.
  • Paul CF, Ho VC, McGeown C, et al. Risk of malignancies in psoriasis patients treated with cyclosporine: a 5 y cohort study. J Invest Dermatol. 2003;120(2):211–216. doi:10.1046/j.1523-1747.2003.12040.x
  • Hans CP, Weisenburger DD, Greiner TC, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood. 2004;103(1):275–282. doi:10.1182/blood-2003-05-1545
  • Liu Y, Barta SK. Diffuse large B-cell lymphoma: 2019 update on diagnosis, risk stratification, and treatment. Am J Hematol. 2019;94(5):604–616. doi:10.1002/ajh.25460
  • A predictive model for aggressive non-Hodgkin’s lymphoma. N Engl J Med. 1993;329:987–994.
  • Tilly H, Gomes da Silva M, Vitolo U, et al. Diffuse large B-cell lymphoma (DLBCL): ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2012;23(Suppl 5):vii78–vii82. doi:10.1093/annonc/mds273
  • Alballa N, Alyousef A, Alamari A, et al. Hodgkin’s lymphoma in a patient on adalimumab treatment for psoriasis. AME Case Rep. 2018;0 49. doi:10.21037/acr.2018.12.01
  • Takamatsu H, Yoroidaka T. Disappearance of bulky diffuse large B-cell lymphoma after methotrexate/infliximab withdrawal. Int J Hematol. 2022;115(1):1–2. doi:10.1007/s12185-021-03255-y
  • Nocturne G, Boudaoud S, Ly B, et al. Impact of anti-TNF therapy on NK cells function and on immunosurveillance against B-cell lymphomas. J Autoimmun. 2017;80:56–64. doi:10.1016/j.jaut.2017.02.001

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.